磁共振弹性成像肝硬度与非酒精性脂肪性肝病患者心血管疾病风险相关
本研究为横断面分析,纳入105例非酒精性脂肪性肝病(NAFLD)患者,同时行磁共振弹性成像(MRE)和心脏CT。结果显示MRE肝硬度连续值和显著纤维化(≥2.97 kPa)均与冠状动脉钙化(CAC)存在独立关联,显著纤维化者CAC患病率更高。提示MRE显著纤维化患者应进一步评估心血管风险。
要点
- MRE肝硬度连续值与CAC存在独立关联(aOR=2.23,95%CI 1.31-4.34)。
- 显著纤维化(MRE≥2.97 kPa)与CAC独立关联(aOR=3.21-3.53)。
- 显著纤维化者CAC患病率67.6%,无显著纤维化者39.7%。
核心结论
- MRE测定的肝硬度是NAFLD患者存在CAC的独立预测因素,显著纤维化患者应考虑进一步心血管风险评估,无论FRS如何。
研究设计与样本
- 横断面分析,纳入105例NAFLD患者(MR成像质子密度脂肪分数≥5%),同期行心脏CT和MRE。
主要发现
- 平均年龄54.9岁,平均BMI 32.9 kg/m2;49.5%患者有CAC,35.2%有显著纤维化(MRE≥2.97 kPa)。
- 有CAC者较无CAC者年龄更大(63.0 [55.5-67.5] vs 50.0 [39.0-59.0],P<0.001),FRS更高(6.0 [2.0-12.0] vs 1.0 [0.5-3.5],P<0.001)。
- 多变量调整分析中,MRE肝硬度连续值与CAC存在独立关联(性别和年龄调整模型aOR=2.23,95%CI 1.31-4.34,P=0.007;FRS调整模型aOR=2.16,95%CI 1.29-4.09,P=0.008)。
- 显著纤维化(MRE≥2.97 kPa)与CAC独立关联(FRS调整模型和性别年龄调整模型aOR=3.21-3.53,P=0.013-0.017)。
- 显著纤维化者CAC患病率高于无显著纤维化者(67.6% vs 39.7%,P=0.012)。
关键数值与推荐
- CAC定义为冠状动脉钙化评分>0。
- 显著肝纤维化定义为MRE≥2.97 kPa。
临床怎么用
- NAFLD患者若MRE提示显著纤维化(≥2.97 kPa),应考虑进一步心血管风险评估, regardless of FRS。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Magnetic resonance elastography (MRE) is a reliable non-invasive alternative to liver biopsy for assessing liver fibrosis. There are limited data regarding an association between liver fibrosis by MRE and risk of cardiovascular disease (CVD). AIM: To investigate the association of high-risk CVD phenotype determined by coronary artery calcification (CAC) with liver fibrosis by MRE in patients with non-alcoholic fatty liver disease (NAFLD). METHOD: This was a cross-sectional analysis of well-characterised, prospective cohorts including 105 patients with NAFLD (MR imaging-derived proton density fat fraction ≥ 5%) with contemporaneous cardiac computed tomography (CT) and MRE. Patients were assessed using MRE for liver stiffness, and cardiac CT for the presence of CAC (defined as coronary artery calcium score > 0). Odds of presence of CAC were analysed using logistic regression analysis. RESULTS: The average age and body mass index were 54.9 years and 32.9 kg/m2 respectively. In this cohort, 49.5% of patients had CAC and 35.2% had significant liver fibrosis (defined as MRE ≥2.97 kPa). Compared to patients without CAC, those with CAC were older (50.0 [39.0-59.0] vs 63.0 [55.5-67.5], P < 0.001) and had higher Framingham risk score (FRS, 1.0 [0.5-3.5] vs 6.0 [2.0-12.0], P < 0.001). In multivariable-adjusted analysis, liver stiffness as a continuous trait on MRE was independently associated with the presence of CAC in a sex and age-adjusted model (adjusted odd ratios [aOR] = 2.23, 95% confidence interval [CI] = 1.31-4.34, P = 0.007) as well as in a FRS-adjusted model (aOR = 2.16, 95% CI = 1.29-4.09, P = 0.008). When analysed as a dichotomous trait, significant fibrosis (MRE-stiffness ≥2.97 kPa) remained independently associated with the presence of CAC in both FRS-adjusted model and sex and age-adjusted model (aOR = 3.21-3.53, P = 0.013-0.017). In addition, CAC was more prevalent in patients with significant fibrosis than those without as determined by MRE (67.6% vs 39.7%, P = 0.012). CONCLUSION: Liver stiffness determined by MRE is an independent predictor for the presence of CAC in patients with NAFLD. Patients with NAFLD and significant fibrosis by MRE should be considered for further cardiovascular risk assessment, regardless of their FRS.
引用
- Park JG, Jung J, Verma KK, et al. Liver stiffness by magnetic resonance elastography is associated with increased risk of cardiovascular disease in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2021. PMID: 33764550. doi:10.1111/apt.16324
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。